IGF2 and Parkinson disease: Similarly, a different study using 6-hydroxydopamine (6-OHDA) treatment of SH-SY5Y cells and mouse to model PD showed that insulin-like growth factor 2 (IGF2) rescues α-syn toxicity and aggregation [121].